Notably, the observed metabolic heterogeneity, characterized by impaired insulin secretion rather than classic insulin resistance and the nuanced relationship between BMI and lipid profiles, highlights the need for individualized risk assessment beyond conventional markers. Here, INS is linked to Insulin resistance.